Dianthus Therapeutics, Inc.DNTHNASDAQ
Loading
ROE: Returns DecliningContracting
Percentile Rank67
Studio
Year-over-Year Change

Return on equity

Latest
-32.90%
↑ 27% vs avg
Percentile
P67
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
-44.98%
Historical baseline
PeriodValueYoY Change
2025-32.90%-36.5%
2024-24.11%+6.5%
2023-25.79%+33.3%
2022-38.66%-409.2%
2021-7.59%+85.4%
2020-52.07%+4.2%
2019-54.37%-37.7%
2018-39.49%+44.0%
2017-70.53%+32.4%
2016-104.30%-